Skip to main content
SpringerLink
Log in

Extreme Hypofraktionierung beim lokalisierten Prostatakarzinom. 5-Jahresergebnisse der HYPO-RT-PC-Studie: Kommentar II

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: HYPO-RT-PC randomized trial. 5-year results: Commentary II

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Incrocci L et al (2016) Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol 17:1061–1069

    Article  Google Scholar 

  2. Dearnaley D et al (2016) Conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer: 5 year outcomes of the randomised, non-inferiority, phase 3 CHHiPtrial. Lancet Oncol 17:1047–1060

    Article  Google Scholar 

  3. Catton C et al (2017) Randomized trial of a hypofractionated radiation regimenfor the treatment of localized prostate cancer. J Clin Oncol 35:1884–1890

    Article  CAS  Google Scholar 

  4. Morgan SC et al (2019) Hypofractionated radiation therapy for localized prostatecancer: an ASTRO, ASCO and AUA evidence-based guidline. J Urol 201:528–534

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Radioonkologie, MUW-Wien – Allgemeines KH, Währinger Gürtel 18–20, 1090, Wien, Österreich

    Gregor Goldner

Authors
  1. Gregor Goldner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregor Goldner.

Ethics declarations

Interessenkonflikt

G. Goldner gibt an, dass kein Interessenkonflikt besteht.

Additional information

Zu dieser Originalpublikation liegt ein weiterer Literaturkommentar vor (DOI https://doi.org/10.1007/s00066-019-01535-5, Kommentar I).

Originalpublikation

Widmark A, Gunnlaugsson A, Beckman L et al (2019) Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5‑year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial. Lancet. Jun 18. pii: S0140-6736(19)31131‑6. https://doi.org/10.1016/S0140-6736(19)31131-6.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goldner, G. Extreme Hypofraktionierung beim lokalisierten Prostatakarzinom. 5-Jahresergebnisse der HYPO-RT-PC-Studie: Kommentar II. Strahlenther Onkol 195, 1119–1121 (2019). https://doi.org/10.1007/s00066-019-01536-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-019-01536-4

Search

Navigation